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ABSTRACT 
 
To discover new bioactive lead compounds for medicinal purposes, herein, 2(1-
adamantylthio)pyridine and derivatives (1-10) were prepared and tested for antibacterial (agar 
dilution method against 27 strains of microorganisms), antimalarial (against Plasmodium   
falciparum) and anticancer (MOLT-3, HepG2, HuCCA-1 and A549) activities. Results 
showed that all the tested derivatives selectively exerted antigrowth activity against Strepto-
cocci at 15-30 µg/mL. 3-Substituted (R) thiopyridines; 3 (R = NAc2), 5 (R = OH) and 6 (R = 
Br) exhibited antibacterials, antimalarials and anticancers. Significantly, 6-(1-adamantylthio) 
nicotinonitrile (10) is a promising antibacterial which selectively displays antigrowth activity 
against Vibrio cholerae, Vibrio parahaemolyticus, Edwardsiella tarda and β-hemolytic Strep-
tococcus group A with minimum inhibitory concentration of 30 µg/mL. The findings reveal 
that these 1-adamantylthiopyridines represent a novel class of antibacterial, antimalarial and 
anticancer agents with potential medicinal values. 
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INTRODUCTION 
 
Pyridines constituting sulfide (Ballell et 
al., 2005), sulfoxide (Scozzafava et al., 
2001), sulfone (Centrone and Lowary, 
2004) and sulfonamide (Joshi et al., 2004) 
have shown to be active antimicrobials and 
herbicides (Parrish et al., 2001; Doweyko et 
al., 1983). In the previous work, we have 
found that 3-substituted (R) pyridines hav-
ing 1-adamantylthio moiety such as 
thiopyridines 1-6 (Figure 1) exert antibacte-
rial activity (Prachayasittikul et al., 2008a). 
Such 3-substituents are groups or atoms 
with high electronegativity (R = OC2H5, 
OAc, NAc2, Br, OH). To compare their 
bioactivity, it is of great interest to explore 
thiopyridines bearing 3-carbonyl (carbox-
ylic acid and amide) and nitrile functions. 
However, antimalarial and anticancer ac-
tivities of 1-adamantylthiopyridines have 
not yet been reported. As a continuing 
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study, to search for new simple-small mo-
lecular lead compounds with medicinal val-
ues, we have focused on antibacterial, an-
timalarial and anticancer activities of other 
3-substituted thiopyridine analogs contain-
ing 1-adamantylthio group. The interested 
target compounds are 1-adamantylthio-
nicotinic acid, nicotinamide and nitrile de-
rivatives (7-10) as shown in Figure 1. The 
compounds 7-10 were prepared using de-
oxydative substitution reaction of pyridine 
1-oxides by thiol (Prachayasittikul and 
Bauer, 1985). The present study reveals  
antibacterial activity of the thionicotinic 
acid and derivatives 7-10 as well as antima-
larial and anticancer activities of the 
thiopyridines 1-10. 
 
MATERIALS AND METHODS 
 
General 
Melting points were determined on an 
Electrothermal melting point apparatus 
(Electrothermal 9100) and are reported 
without correction. 1H-NMR spectra were 
recorded on a Bruker AM 400 instrument 
with a 400/100 MHz operating frequency 
using deuterochloroform or DMSO-d6 solu-
tion with tetramethylsilane as internal stan-
dard. Infrared spectra (IR) were obtained on 
Perkin Elmer System 2000 FTIR. Column 
chromatography was carried out using silica 
gel 60 (0.063–0.200 mm). Thin layer chro-
matography (TLC) was performed on silica 
gel 60 PF254 (cat. No. 7747 E., Merck).  
Solvents were distilled prior to use. 
Chemicals for the synthesis were of ana-
lytical grade.  
Reagents for cell culture and assays 
were the following: 
RPMI (Gibco and Hyclone laboratories, 
USA) 
HEPES, L-glutamine, penicillin-strepto-
mycin, sodium pyruvate and glucose 
(Sigma, USA) 
Ham’s/F12, DMEM and fetal bovine se-
rum (Hyclone laboratories, USA) 
Gentamicin sulfate (Government Phar-
maceutical Organization, Thailand) 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (Sigma-Aldrich, 
USA). 
 
The tested compounds 1-10 
The tested compounds are 2-(1-
adamantylthio)-3-ethoxypyridine (1), 2-(1-
adamantylthio)-3-acetoxypyridine (2), N-
acetyl-2-(1-adamantylthio)-3-acetamidopy-
ridine (3), 2-(1-adamantylthio)-3-bromo-
pyridine (4), 2-(1-adamantylthio)-5-
hydroxypyridine (5), 3-(1-adamantylthio)-
5-bromopyridine (6),  2-(1-adamantyl-
thio)nicotinic acid (7),  2-(1-adaman-
tylthio)nicotinamide(8),  2-(1-adaman- 
tylthio)nicotinonitrile (9) and 6-(1-adaman- 
tylthio)nicotinonitrile (10). The compounds 
1-6 (Prachayasittikul et al., 1991) and 7-10 
(Prachayasittikul and Bauer, 1985) were 
prepared as previously described. 
 
Figure 1: Structure of thiopyridines 1-10 
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Cell cultures 
Plasmodium falciparum chloroquine resis-
tant (T9.94) 
Human erythrocytes (type O) infected 
with P. falciparum chloroquine resistant 
(T9.94) were maintained in continuous cul-
ture, according to the method described pre-
viously (Trager and Jensen, 1976). RPMI 
1640 culture medium supplemented with 
25 mM of HEPES, 40 mg/L gentamicin sul-
fate and 10 mL of human serum was used 
in continuous culture. 
 
Human cholangiocarcinoma (HuCCA-1)  
HuCCA-1 cells were grown in 
Ham’s/F12 medium containing 2 mM L-
glutamine supplemented with 100 U/mL 
penicillin-streptomycin and 10 % fetal bo-
vine serum. 
 
Human lung cancer (A549, non small cell) 
Human lung cancer cells were grown in 
Ham’s/F12 medium containing 2 mM L-
glutamine supplemented with 100 U/mL 
penicillin-streptomycin and 10% fetal bo-
vine serum. 
 
Hepatocarcinoma (HepG2) 
HepG2 cells were grown in DMEM 
medium supplemented with 100 U/mL 
penicillin-streptomycin and 10 % fetal bo-
vine serum. 
T-lymphoblast (MOLT-3, acute lym-
phoblastic leukemia) 
MOLT-3 cells were grown in RPMI 
1640 medium supplemented with 100 U/mL 
penicillin-streptomycin, sodium pyruvate, 
4.5 g/L glucose, 2 mM L-glutamine and 
10 % fetal bovine serum. 
 
Biological activities 
Antibacterial assay 
Antibacterial activity of the tested com-
pounds was performed using agar dilution 
method as previously described (Pracha-
yasittikul et al., 2008b). Briefly, the tested 
compounds dissolved in DMSO were indi-
vidually mixed with 1 mL Müller Hinton 
(MH) broth. The solution was then trans-
ferred to the MH agar solution to yield the 
final concentrations of 15 and 30 µg/mL. 
Twenty seven strains of microorganisms, 
cultured in MH broth at 37 °C for 24 h, 
were diluted with 0.9 % normal saline solu-
tion to adjust the cell density of 3×109 
cell/mL. The organisms were inoculated 
onto each plate and further incubated at 
37 oC for 18-48 h. Compounds which pos-
sessed high efficacy to inhibit bacterial cell 
growth were analyzed. The microorganisms 
used for the activity testing are shown in 
Table 1. 
 
Table 1: Twenty-seven strains of microorganisms for antibacterial activity testing 
Bacteria 
Gram-negative bacteria  
Escherichia coli ATCC 25922 Citrobacter freundii 
Klebsiella pneumoniae ATCC 700603 Enterobacter aerogenes 
Serratia marcescens ATCC 8100 Enterobacter cloacae 
Pseudomonas aeruginosa ATCC 27853 Serratia rubidaca 
Edwardsiella tarda Morganella morganii 
Shigella dysenteriae Providencia rettgeri 
Shigella flexneri Providencia alcalifaciens 
Salmonella paratyphi A Vibrio cholera 
Salmonella typhi Vibrio parahaemolyticus 
Salmonella enteritidis Aeromonas hydrophila 
Citrobacter diversus  
Gram-positive bacteria  
Staphylococcus aureus ATCC 25923 β-hemolytic Streptococcus group A 
Bacillus subtilis ATCC 6633 α-hemolytic Streptococcus spp. 
Staphylococcus saprophyticus Streptococcus group D enterococcus 
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Antimalarial assay 
Antimalarial activity of the tested com-
pounds was evaluated against P. falciparum 
chloroquine resistant (T9.94) using the lit-
erature method (Trager and Jensen, 1976). 
Before performing the experiment, P. 
falciparum culture was synchronized by 
using sorbitol induced hemolysis according 
to the method of Lambros and Vanderberg 
(1979) to obtain only ring-infected cells and 
then incubated for 48 h prior to the drug 
testing to avoid effect of sorbitol. 
The experiments were started with syn-
chronized suspension of 0.5 % to 1 % in-
fected red blood cell during ring stage. 
Parasites were suspended with culture me-
dium supplemented with 15 % human se-
rum to obtain 10 % cell suspension. The 
parasite suspension was put into 96-well 
microculture plate; 50 µL in each well and 
then add 50 µL of various tested drug con-
centrations. These parasite suspensions 
were incubated for 48 h in the atmosphere 
of 5 % CO2 at 37 °C. The percents para-
sitemia of control and drug-treated groups 
were examined by microscopic technique 
using methanol-fixed Giemsa stained of 
thin smear blood preparation. 
 
Cytotoxic assay 
Cell lines were plated in 96 well mi-
croplates 100 µL/well at a density of 5x103 
to 2x104 cells/well. Background control 
wells contained the same volume of com-
plete culture medium .The microplate was 
incubated for 24 h at 37 °C, 5 % CO2 - 
95 % humidity, anti-cancer drugs at various 
concentration were added and further incu-
bated for 48 h. Cell viability was deter-
mined (Mosman, 1983; Carmichael et al., 
1987; Tominaga et al., 1999) by staining 
with MTT assay (3-(4,5-dimethylthiazol-2-
yl)-2, 5-diphenyl tetrazolium bromide). The 
reagent was dissolved in PBS at 5 mg/mL 
and filtered to sterilize and remove a small 
amount of insoluble residue present in some 
batches of MTT. The MTT solution (10 µL 
/100µL medium) was added to all wells of 
the assay, and plates were incubated at 
37 °C, 5 % CO2 – 95 % humidity for 2-4 h. 
Subsequently, 100 µL DMSO was added to 
dissolve the resulting formazan by sonica-
tion. The plates were read on a microplate 
reader (Molecular Devices, USA), using a 
test wavelength at 550 nm and a reference 
wavelength at 650 nm. 
For XTT assay, the suspension cell was 
MOLT-3 cell line. It was seeded in flat 96-
well plates at a density of 2 x 104 and 5x103 
cells/well. The incubation and exposure 
processes were as described in the MTT 
assay. Preparation of the XTT, a stock XTT 
solution of 5 mL (1 mg/mL) was mixed 
with 100 µL of PMS solution (0.383 mg/mL); 
then, 50 µL of this mixture was added into 
each well of the tested plates and incubated 
for 4 h. The orange-colored of formazan 
compound thus formed and the absorbance 
was measured at 492 and 690 nm, respec-
tively. 
IC50 values were determined as the drug 
and sample concentration at 50 % inhibition 
of the cell growth. 
 
RESULTS AND DISCUSSION 
 
Chemistry 
1-Adamantylthio derivatives of nico-
tinic acid, nicotinamide and nicotinonitrile 
7-10 were prepared (Prachayasittikul and 
Bauer, 1985) from the reaction of nicotinic 
acid, nicotinamide and nicotinonitrile 1-
oxides with 1-adamantanethiol in refluxing 
acetic anhydride. Similarly, 1-adamantyl-
thiopyridines 1-6 were obtained from the 
reaction of corresponding 3-substituted 
pyridine 1-oxides as described (Pracha-
yasittikul et al., 1991). Structures of com-
pounds 1-10 were confirmed by IR, 1H 
NMR spectral data and melting points.  
 
Biological activities 
Antibacterial activity 
The thionicotinic acid, nicotinamide and 
nitrile derivatives 7-10 were evaluated for 
antibacterial activity against 27 strains of 
microorganisms using agar dilution method 
as previously described (Prachayasittikul et 
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al., 2008b). It was found that (Table 2) the 
tested thiopyridine derivatives 7-10 selec-
tively exerted antigrowth activity against 
Streptococci at 15-30 µg/mL. Significantly, 
6-(1-adamantythio) nicotinonitrile (10) was 
the most active antibacterials exhibiting 
complete inhibition against β-hemolytic 
Streptococcus group A with minimum in-
hibitory concentration (MIC) of 30 µg/mL. 
In addition, the compound 10 also showed 
complete inhibition against V. cholerae, V. 
parahaemolyticus and E. tarda at the same 
concentration. Moreover, partial inhibition 
of the tested compounds 7-10 was also ob-
served. Particularly, S. paratyphi A was in-
hibited (50 %) by the tested thiopyridines 7-
9 at 15 µg/mL, whereas 75 % inhibition (at 
30 µg/mL) was observed for thionicotinoni-
trile compound 10. The compound 10 at 
30 µg/mL also showed partial antigrowth 
activity, 75 % inhibitions against other or-
ganisms e. g. α-hemolytic Streptococcus 
spp., Streptococcus group D enterococcus, 
A. hydrophila and S. aureus ATCC 25923. 
In addition, 50 % inhibitions against S.   
saprophyticus, S. dsysenteriae and B. sub-
tilis ATCC 6633 at 30 µg/mL were noted 
for nitrile analog 10. Recently (Prachaya-
sittikul et al., 2008a), we have found that 
thiopyridine compounds 1-6 display growth 
inhibition (50-75 %) against Streptococci at 
15 µg/mL. In particular the derivatives 3, 5 
and 6 exhibit complete inhibition against β-
hemolytic Streptococcus group A with MIC 
of 30 µg/mL.  
However, the present study showed that 
among the tested thiopyridines 7-10 as 
compared with the reported analogs 1-6 
(Prachayasittikul et al., 2008a), the thioni-
trile 10 (R = CN) was the most promising 
antibacterial. As a result, the thionicotinoni-
trile 10 exerted complete inhibition against 
many tested microorganisms e. g. β-
hemolytic Streptococcus group A, V. chol-
erae, V. parahaemolyticus and E. tarda 
with MIC of 30 µg/mL. Apparently, 1-
adamantylthiopyridine derivatives 1-10 
bearing substituents with high electronega-
tivity and or electron withdrawing effect at 
C-3 all selectively inhibit the growth of β-
hemolytic Streptococcus group A, α-
hemolytic Streptococcus spp. and Strepto-
coccus group D enterococcus at concentra-
tions range 15-30 µg/mL. Furthermore, the 
position of 1-adamantylthio group can be at 
2-(α-) or 6-(α) and 5-(β-) positions of the 
pyridine ring. However, recently, β- (1-
adamantylthio) analogs of 3-picoline and 4-
phenylpyridine as antimicrobials and anti-
malarials have been reported by our group 
(Prachayasittikul et al., 2009). 
 
 
 
Table 2: Antibacterial activity of 1-adamantylthiopyridines 7-10 
 
Inhibition (%) Compound Activity 
15 µg/mL 30 µg/mL 
7 active 50a,b, 75c,d,e 50f,g,h, 75a,b,i,j 
8 active 50b, 75c,d,e 50h 
9 active 50b, 75c,d,e 50a 
10 active - 50h,k,l, 75b,d,e,f,g, 100a,c,i,j 
Ampicillin* activeg,l   
 
Inhibition against aE. tarda, bS. paratyphi A, cβ-hemolytic Streptococcus group A, dα-hemolytic Strepto-
coccus spp., eStreptococcus group D enterococcus, fA. hydrophila, gS. aureus ATCC 25923, hS. sap-
rophyticus, iV. cholerae, jV. parahaemolyticus, kS. dysenteriae, lB. subtilis ATCC 6633 
*At 10 µg/mL showed 100 % growth inhibition against S. aureus ATCC 25923 and B. subtilis ATCC 
6633  
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So far, the antibacterial activity of 1-
adamantylthionicotinic acid, amide and ni-
trile derivatives 7-10 has not been reported. 
Related compound e. g. 2-mercaptonicotin-
amide was reported to be the most active 
one, which inhibited the growth of Myco-
bacterium kansasii, among the tested de-
rivatives (Klimesova and Odlerova, 1993). 
Recently, we have found that nicotinic acid 
copper complex with carboxylic acids ex-
hibit antimicrobial activity (Suksrichavalit 
et al., 2008; Suksrichavalit et al., 2009). 
The study demonstrates that 1-adamantyl-
thionicotinic acid, its amide and nitrile de-
rivatives 7-10 are novel antibacterials with 
potential medicinal values, particularly, the 
thionicotinonitrile 10. 
 
Antimalarial activity 
The thiopyridines 1-10 were assayed for 
antimalarial activity against P. falciparum 
chloroquine resistant (T9.94). Results (Ta-
ble 3) showed that 2-(1-adamantylthio) 
nicotinonitriles (9 and 10) and 3-substituted 
thiopyridines 2-5 (R=OAc, NAc2, Br, OH) 
and 6 exhibited fair activity with IC50 10-6 - 
<10-5 M, whereas thionicotinic acid 7 and 
nicotinamide 8 together with 2-(1-
adamantylthio)-3-ethoxypyridine (1) were 
inactive showing IC50 > 10-5 M. Interest-
ingly, the active antimalarials (2-6 and 9-
10) having 1-adamantylthio moiety at either 
α- or β-position on the pyridine ring are 
manifested. Such observation has been 
found for β-thio analogs of 3-picoline and 
4-phenylpyridine (Prachayasittikul et al., 
2009). Based on the literatures, antimalarial 
activity of the tested thiopyridines 1-10 has 
not been reported. Thus, thiopyridine ana-
logs 2-6 and 9-10 are novel antimalarials. 
 
Anticancer activity 
Anticancer activity of the 1-adamantyl-
thiopyridines 1-10 was performed against 
four cell lines; MOLT-3, HepG2, HuCCA-1 
and A549 using etoposide and/or doxorubi-
cin as positive controls. It was observed 
(Table 4) that 1-adamantylthionicotinic 
acid, its amide and nitrile derivatives (7-10) 
were inactive (IC50 > 50 µg/mL) to all the 
tested cell lines, except for thionicotinoni-
trile compound 9 which begin to show 
some activity with IC50 of 50 µg/mL 
against HepG2 cell line. However, nicoti-
nonitrile without thio functionality analog 
of 3,4-disubstituted pyrazoles was reported 
to be anti-tumor cyclin-dependent inhibitor 
(Lin et al., 2007). The 3-substituted 
thiopyridines 5 (R = OH) and 6 were active 
against all the tested cell lines with IC50 
range 17.90-45.00 µg/mL, while N-acetyl-
2-(1-adamantylthio)-3-acetamidopyridine 
(3) selectively exerted anticancer activity 
against only MOLT-3 cell line with IC50 of 
16.10 µg/mL. Particularly, MOLT-3 cell 
line was inhibited not only by the com-
pound 3, but also by 2-(1-adamantylthio)-5-
hydroxypyridine (5) and 3-(1-adamantyl-
thio)-5-bromopyridine (6). Such thiopyri- 
dines (3, 5 and 6) showed comparable anti-
cancer activity, in which the thioacetami-
dopyridine 3 was the most active with IC50 
of 16.10 µg/mL. Interestingly, thionicotinic 
acid (7), amide (8) and nitrile (10) deriva-
tives are inactive agents. However, antican-
cer activity of these compounds has not 
been reported. So far, N-acetyl-3-acet-
amidopyridine and its 2-isomer were shown 
to significantly inhibit the replication of in-
fluenza A virus (Pushkarskaya et al., 1971). 
Now, it comes to the point that the active 1-
adamantylthiopyridines 3, 5 and 6 are new 
types of analogs with anticancer activity.
 
 
Table 3: Antimalarial activity of 1-adamantylthiopyridines 1-10 
 
Compound Activity IC50 (M) 
1,7,8 inactive >10-5 
2,3,4,5,6,9,10 fair 10-6- <10-5 
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Table 4: Anticancer activity of 1-adamantylthiopyridines 1-10 
 
IC50 (µg/mL)a,b Compoundc 
MOLT-3 HepG2 HuCCA-1 A549 
3 16.10±1.11 inactive inactive inactive 
5 17.90±0.18 35.00±0.00 44.00±2.83 45.00±0.00 
6 18.34±0.84 41.00±1.41 37.00±4.24 45.00±0.71 
7 inactive inactive inactive inactive 
8 inactive inactive inactive inactive 
9 inactive 50.00±0.00 inactive inactive 
10 inactive inactive inactive inactive 
etoposide 0.02±0.00 12.00±0.00 - - 
doxorubicin - 0.23±0.00 0.50±0.00 0.45±0.07 
 
a : When IC50 > 50 µg/mL denote inactive for anticancer activity. 
b :  The tests were performed in triplicate. 
c :  Results of compounds 1, 2 and 4 were not obtained, due to their insolubility. 
 
Based on the outcome of activity 
testings, it is noteworthy that 1-adamantyl-
thiopyridines 3, 5 and 6 all exert antibacte-
rial (against β-hemolytic Streptococcus 
group A), antimalarial and anticancer 
(against MOLT-3) activities. In addition, 
the compounds 5 and 6 also showed anti-
cancer activity against all other tested cell 
lines (HepG2, HuCCA-1 and A549). Fur-
thermore, the 6-(1-adamantylthio) nicoti-
nonitrile (10) selectively showed complete 
inhibition against β-hemolytic Streptococ-
cus group A, V. cholerae, V. parahaemo-
lyticus and E.tarda. Antimalarial activity 
was also observed for the nicotinonitrile 10 
as well as its 2-isomer; 2-(1-adamantylthio) 
nicotinonitrile 9. In relating their structures 
and activities, it can be concluded that 1-
adamantylthio analogs of 3-substituted thio-
pyridines require substituents with high 
electronegativity atoms (O, Br) and/or elec-
tron withdrawing groups (NAc2, CN). 
Moreover, such active 1-adamantyl-
thiopyridines are simple-small molecules 
which are readily achieved by one pot reac-
tion. Significantly, the thionicotinonitrile 
(10) is a promising antibacterial which se-
lectively exhibits antigrowth activity 
against β-hemolytic Streptococcus group A, 
V. cholerae, V. parahaemolyticus and E. 
tarda with MIC of 30 µg/mL. 
 
CONCLUSION 
 
The findings demonstrate that 1-
adamantylthiopyridines represent a novel 
class of bioactive compounds, particularly, 
3, 5 and 6 are analogs of interesting anti-
bacterials, antimalarials and anticancers. 
However, all the tested derivatives selec-
tively exhibit growth inhibition against 
Streptococci at 15-30 µg/mL. Significantly, 
6-(1-adamantylthio) nicotinonitrile (10) is a 
promising antibacterial agent with potential 
for further development as pharmaceutical 
uses and applications. 
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